MedPath
FDA Approval

Sildenafil

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 12, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Sildenafil(10 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Taro Pharmaceutical Industries, Ltd.

Taro Pharmaceuticals U.S.A. Inc.

600072078

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sildenafil

Product Details

NDC Product Code
51672-4231
Application Number
ANDA215522
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 12, 2023
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
SUCRALOSEInactive
Code: 96K6UQ3ZD4Class: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
Code: BW9B0ZE037Class: ACTIMQuantity: 10 mg in 1 mL
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
XANTHAN GUMInactive
Code: TTV12P4NEEClass: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95KClass: IACT
© Copyright 2025. All Rights Reserved by MedPath
Sildenafil - FDA Approval | MedPath